Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-05-07 01:49 |
6k: Kitov Announces $10 million Registered Direct Offering
|
English | 126.8 KB | ||
| 2020-05-07 01:49 |
6k: Kitov Announces $10 million Registered Direct Offering
|
English | 38.6 KB | ||
| 2020-05-07 01:29 |
Schedule 13G filing with the SEC by Sabby Volatility Warrant Master Fund, Ltd. …
|
English | 70.9 KB | ||
| 2020-05-07 01:29 |
Schedule 13G filing with the SEC by Sabby Volatility Warrant Master Fund, Ltd. …
|
English | 38.2 KB | ||
| 2020-05-06 17:05 |
Kitov Announces $10 million Registered Direct Offering
|
English | 53.9 KB | ||
| 2020-05-06 17:05 |
Kitov Announces $10 million Registered Direct Offering
|
English | 38.1 KB | ||
| 2020-05-05 01:14 |
FORM D-Notice of Exempt Offering of Securities
|
English | 159.6 KB | ||
| 2020-05-05 01:14 |
FORM D-Notice of Exempt Offering of Securities
|
English | 38.8 KB | ||
| 2020-05-04 18:13 |
Company Presentation - May 2020
|
English | 9.4 MB | ||
| 2020-05-04 18:13 |
Company Presentation - May 2020
|
English | 38.4 KB | ||
| 2020-04-20 18:26 |
6K: Material Agreement and Press Release: Kitov Pharma Ltd. Announces Cash Proc…
|
English | 885.5 KB | ||
| 2020-04-20 18:26 |
6K: Material Agreement and Press Release: Kitov Pharma Ltd. Announces Cash Proc…
|
English | 38.8 KB | ||
| 2020-04-20 17:21 |
Kitov Pharma Ltd. Announces Cash Proceeds of $6.5 Million from Exercise of Warr…
|
English | 216.9 KB | ||
| 2020-04-20 17:21 |
Kitov Pharma Ltd. Announces Cash Proceeds of $6.5 Million from Exercise of Warr…
|
English | 38.2 KB | ||
| 2020-04-01 01:54 |
Amendment No. 1 to annual report on Form 20-F for the fiscal year ended 31.12.…
|
English | 454.0 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
